| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |